EV-103: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for locally advanced or metastatic urothelial cancer Meeting Abstract
| Authors: | Hoimes, C. J.; Rosenberg, J. E.; Petrylak, D. P.; Carret, A. S.; Melhem-Bertrandt, A.; Flaig, T. W. |
| Abstract Title: | EV-103: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for locally advanced or metastatic urothelial cancer |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 286s |
| Language: | English |
| ACCESSION: | WOS:000487345803360 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS4593 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4593 -- Source: Wos |
